Evaluation of HER2DX Assay on Treatment Decisions in Patients With Early Stage HER2+ Breast Cancer: the HER2BREASTDX

Clinical trial NCT06723990 · RECRUITING

Trial details

NCT number: NCT06723990
Sponsor: European Institute of Oncology
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start date: 2024-10-24
Primary completion: 2027-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.